Global Hormonal Supplements Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Hormonal Supplements: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Hormonal Supplements Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Tablets
1.2.3 Liquid
1.2.4 Powders
1.2.5 Chewables
1.2.6 Capsules
1.3 Market Segmentation by Application
1.3.1 Global Hormonal Supplements Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Hormonal Supplements Revenue Estimates and Forecasts 2020-2031
2.2 Global Hormonal Supplements Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Hormonal Supplements Sales Estimates and Forecasts 2020-2031
2.4 Global Hormonal Supplements Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Hormonal Supplements Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Hormonal Supplements Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Tablets Market Size by Manufacturers
3.5.2 Liquid Market Size by Manufacturers
3.5.3 Powders Market Size by Manufacturers
3.5.4 Chewables Market Size by Manufacturers
3.5.5 Capsules Market Size by Manufacturers
3.6 Global Hormonal Supplements Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Hormonal Supplements Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Hormonal Supplements Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Hormonal Supplements Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Hormonal Supplements Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Hormonal Supplements Sales and Revenue by Type (2020-2031)
6.4 North America Hormonal Supplements Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Hormonal Supplements Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Hormonal Supplements Sales and Revenue by Type (2020-2031)
7.4 Europe Hormonal Supplements Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Hormonal Supplements Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Hormonal Supplements Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Hormonal Supplements Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Hormonal Supplements Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Hormonal Supplements Sales and Revenue by Type (2020-2031)
9.4 Central and South America Hormonal Supplements Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Hormonal Supplements Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Hormonal Supplements Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Hormonal Supplements Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Hormonal Supplements Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Nature's Way
11.1.1 Nature's Way Corporation Information
11.1.2 Nature's Way Business Overview
11.1.3 Nature's Way Hormonal Supplements Product Models, Descriptions and Specifications
11.1.4 Nature's Way Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Nature's Way Hormonal Supplements Sales by Product in 2024
11.1.6 Nature's Way Hormonal Supplements Sales by Application in 2024
11.1.7 Nature's Way Hormonal Supplements Sales by Geographic Area in 2024
11.1.8 Nature's Way Hormonal Supplements SWOT Analysis
11.1.9 Nature's Way Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Hormonal Supplements Product Models, Descriptions and Specifications
11.2.4 Novartis AG Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Novartis AG Hormonal Supplements Sales by Product in 2024
11.2.6 Novartis AG Hormonal Supplements Sales by Application in 2024
11.2.7 Novartis AG Hormonal Supplements Sales by Geographic Area in 2024
11.2.8 Novartis AG Hormonal Supplements SWOT Analysis
11.2.9 Novartis AG Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Corporation Information
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. Hormonal Supplements Product Models, Descriptions and Specifications
11.3.4 Pfizer Inc. Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Pfizer Inc. Hormonal Supplements Sales by Product in 2024
11.3.6 Pfizer Inc. Hormonal Supplements Sales by Application in 2024
11.3.7 Pfizer Inc. Hormonal Supplements Sales by Geographic Area in 2024
11.3.8 Pfizer Inc. Hormonal Supplements SWOT Analysis
11.3.9 Pfizer Inc. Recent Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Corporation Information
11.4.2 Merck & Co. Business Overview
11.4.3 Merck & Co. Hormonal Supplements Product Models, Descriptions and Specifications
11.4.4 Merck & Co. Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Merck & Co. Hormonal Supplements Sales by Product in 2024
11.4.6 Merck & Co. Hormonal Supplements Sales by Application in 2024
11.4.7 Merck & Co. Hormonal Supplements Sales by Geographic Area in 2024
11.4.8 Merck & Co. Hormonal Supplements SWOT Analysis
11.4.9 Merck & Co. Recent Developments
11.5 Bayer AG
11.5.1 Bayer AG Corporation Information
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Hormonal Supplements Product Models, Descriptions and Specifications
11.5.4 Bayer AG Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Bayer AG Hormonal Supplements Sales by Product in 2024
11.5.6 Bayer AG Hormonal Supplements Sales by Application in 2024
11.5.7 Bayer AG Hormonal Supplements Sales by Geographic Area in 2024
11.5.8 Bayer AG Hormonal Supplements SWOT Analysis
11.5.9 Bayer AG Recent Developments
11.6 Nature's Bounty Co.
11.6.1 Nature's Bounty Co. Corporation Information
11.6.2 Nature's Bounty Co. Business Overview
11.6.3 Nature's Bounty Co. Hormonal Supplements Product Models, Descriptions and Specifications
11.6.4 Nature's Bounty Co. Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Nature's Bounty Co. Recent Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Corporation Information
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Hormonal Supplements Product Models, Descriptions and Specifications
11.7.4 GlaxoSmithKline Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 GlaxoSmithKline Recent Developments
11.8 NOW Foods
11.8.1 NOW Foods Corporation Information
11.8.2 NOW Foods Business Overview
11.8.3 NOW Foods Hormonal Supplements Product Models, Descriptions and Specifications
11.8.4 NOW Foods Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 NOW Foods Recent Developments
11.9 Life Extension
11.9.1 Life Extension Corporation Information
11.9.2 Life Extension Business Overview
11.9.3 Life Extension Hormonal Supplements Product Models, Descriptions and Specifications
11.9.4 Life Extension Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Life Extension Recent Developments
11.10 Garden of Life
11.10.1 Garden of Life Corporation Information
11.10.2 Garden of Life Business Overview
11.10.3 Garden of Life Hormonal Supplements Product Models, Descriptions and Specifications
11.10.4 Garden of Life Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Garden of Life Recent Developments
11.11 Suntory Holdings
11.11.1 Suntory Holdings Corporation Information
11.11.2 Suntory Holdings Business Overview
11.11.3 Suntory Holdings Hormonal Supplements Product Models, Descriptions and Specifications
11.11.4 Suntory Holdings Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Suntory Holdings Recent Developments
11.12 Thorne Research
11.12.1 Thorne Research Corporation Information
11.12.2 Thorne Research Business Overview
11.12.3 Thorne Research Hormonal Supplements Product Models, Descriptions and Specifications
11.12.4 Thorne Research Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Thorne Research Recent Developments
11.13 Meiji Holdings Co.
11.13.1 Meiji Holdings Co. Corporation Information
11.13.2 Meiji Holdings Co. Business Overview
11.13.3 Meiji Holdings Co. Hormonal Supplements Product Models, Descriptions and Specifications
11.13.4 Meiji Holdings Co. Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Meiji Holdings Co. Recent Developments
11.14 Swanson Health Products
11.14.1 Swanson Health Products Corporation Information
11.14.2 Swanson Health Products Business Overview
11.14.3 Swanson Health Products Hormonal Supplements Product Models, Descriptions and Specifications
11.14.4 Swanson Health Products Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Swanson Health Products Recent Developments
11.15 Herbalife Nutrition
11.15.1 Herbalife Nutrition Corporation Information
11.15.2 Herbalife Nutrition Business Overview
11.15.3 Herbalife Nutrition Hormonal Supplements Product Models, Descriptions and Specifications
11.15.4 Herbalife Nutrition Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Herbalife Nutrition Recent Developments
11.16 USANA Health Sciences
11.16.1 USANA Health Sciences Corporation Information
11.16.2 USANA Health Sciences Business Overview
11.16.3 USANA Health Sciences Hormonal Supplements Product Models, Descriptions and Specifications
11.16.4 USANA Health Sciences Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 USANA Health Sciences Recent Developments
11.17 MegaFood
11.17.1 MegaFood Corporation Information
11.17.2 MegaFood Business Overview
11.17.3 MegaFood Hormonal Supplements Product Models, Descriptions and Specifications
11.17.4 MegaFood Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 MegaFood Recent Developments
11.18 Nutrascriptives
11.18.1 Nutrascriptives Corporation Information
11.18.2 Nutrascriptives Business Overview
11.18.3 Nutrascriptives Hormonal Supplements Product Models, Descriptions and Specifications
11.18.4 Nutrascriptives Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Nutrascriptives Recent Developments
11.19 Sisterly
11.19.1 Sisterly Corporation Information
11.19.2 Sisterly Business Overview
11.19.3 Sisterly Hormonal Supplements Product Models, Descriptions and Specifications
11.19.4 Sisterly Hormonal Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Sisterly Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Hormonal Supplements Industry Chain
12.2 Hormonal Supplements Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Hormonal Supplements Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Hormonal Supplements Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Hormonal Supplements Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Hormonal Supplements Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Hormonal Supplements Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Hormonal Supplements Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Hormonal Supplements Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Hormonal Supplements Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Hormonal Supplements Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Hormonal Supplements Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Hormonal Supplements Sales by Region (2020-2025) & (Tons)
Table 8. Global Hormonal Supplements Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Hormonal Supplements Sales by Manufacturers (2020-2025) & (Tons)
Table 11. Global Hormonal Supplements Sales Share by Manufacturers (2020-2025)
Table 12. Global Hormonal Supplements Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Hormonal Supplements Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Hormonal Supplements by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Supplements as of 2024)
Table 16. Global Hormonal Supplements Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Hormonal Supplements Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)
Table 18. Key Manufacturers Hormonal Supplements Manufacturing Base and Headquarters
Table 19. Global Hormonal Supplements Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Hormonal Supplements Sales by Type (2020-2025) & (Tons)
Table 23. Global Hormonal Supplements Sales by Type (2026-2031) & (Tons)
Table 24. Global Hormonal Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Hormonal Supplements Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Hormonal Supplements ASP by Type (2020-2031) & (US$/kg)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Hormonal Supplements Sales by Application (2020-2025) & (Tons)
Table 29. Global Hormonal Supplements Sales by Application (2026-2031) & (Tons)
Table 30. Hormonal Supplements High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Hormonal Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Hormonal Supplements Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Hormonal Supplements ASP by Application (2020-2031) & (US$/kg)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Hormonal Supplements Growth Accelerators and Market Barriers
Table 37. North America Hormonal Supplements Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Hormonal Supplements Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Hormonal Supplements Growth Accelerators and Market Barriers
Table 40. Europe Hormonal Supplements Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Hormonal Supplements Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Hormonal Supplements Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Hormonal Supplements Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Hormonal Supplements Growth Accelerators and Market Barriers
Table 45. Southeast Asia Hormonal Supplements Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Hormonal Supplements Investment Opportunities and Key Challenges
Table 47. Central and South America Hormonal Supplements Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Hormonal Supplements Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Hormonal Supplements Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Nature's Way Corporation Information
Table 51. Nature's Way Description and Major Businesses
Table 52. Nature's Way Product Models, Descriptions and Specifications
Table 53. Nature's Way Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 54. Nature's Way Sales Value Proportion by Product in 2024
Table 55. Nature's Way Sales Value Proportion by Application in 2024
Table 56. Nature's Way Sales Value Proportion by Geographic Area in 2024
Table 57. Nature's Way Hormonal Supplements SWOT Analysis
Table 58. Nature's Way Recent Developments
Table 59. Novartis AG Corporation Information
Table 60. Novartis AG Description and Major Businesses
Table 61. Novartis AG Product Models, Descriptions and Specifications
Table 62. Novartis AG Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 63. Novartis AG Sales Value Proportion by Product in 2024
Table 64. Novartis AG Sales Value Proportion by Application in 2024
Table 65. Novartis AG Sales Value Proportion by Geographic Area in 2024
Table 66. Novartis AG Hormonal Supplements SWOT Analysis
Table 67. Novartis AG Recent Developments
Table 68. Pfizer Inc. Corporation Information
Table 69. Pfizer Inc. Description and Major Businesses
Table 70. Pfizer Inc. Product Models, Descriptions and Specifications
Table 71. Pfizer Inc. Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 72. Pfizer Inc. Sales Value Proportion by Product in 2024
Table 73. Pfizer Inc. Sales Value Proportion by Application in 2024
Table 74. Pfizer Inc. Sales Value Proportion by Geographic Area in 2024
Table 75. Pfizer Inc. Hormonal Supplements SWOT Analysis
Table 76. Pfizer Inc. Recent Developments
Table 77. Merck & Co. Corporation Information
Table 78. Merck & Co. Description and Major Businesses
Table 79. Merck & Co. Product Models, Descriptions and Specifications
Table 80. Merck & Co. Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 81. Merck & Co. Sales Value Proportion by Product in 2024
Table 82. Merck & Co. Sales Value Proportion by Application in 2024
Table 83. Merck & Co. Sales Value Proportion by Geographic Area in 2024
Table 84. Merck & Co. Hormonal Supplements SWOT Analysis
Table 85. Merck & Co. Recent Developments
Table 86. Bayer AG Corporation Information
Table 87. Bayer AG Description and Major Businesses
Table 88. Bayer AG Product Models, Descriptions and Specifications
Table 89. Bayer AG Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 90. Bayer AG Sales Value Proportion by Product in 2024
Table 91. Bayer AG Sales Value Proportion by Application in 2024
Table 92. Bayer AG Sales Value Proportion by Geographic Area in 2024
Table 93. Bayer AG Hormonal Supplements SWOT Analysis
Table 94. Bayer AG Recent Developments
Table 95. Nature's Bounty Co. Corporation Information
Table 96. Nature's Bounty Co. Description and Major Businesses
Table 97. Nature's Bounty Co. Product Models, Descriptions and Specifications
Table 98. Nature's Bounty Co. Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 99. Nature's Bounty Co. Recent Developments
Table 100. GlaxoSmithKline Corporation Information
Table 101. GlaxoSmithKline Description and Major Businesses
Table 102. GlaxoSmithKline Product Models, Descriptions and Specifications
Table 103. GlaxoSmithKline Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 104. GlaxoSmithKline Recent Developments
Table 105. NOW Foods Corporation Information
Table 106. NOW Foods Description and Major Businesses
Table 107. NOW Foods Product Models, Descriptions and Specifications
Table 108. NOW Foods Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 109. NOW Foods Recent Developments
Table 110. Life Extension Corporation Information
Table 111. Life Extension Description and Major Businesses
Table 112. Life Extension Product Models, Descriptions and Specifications
Table 113. Life Extension Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 114. Life Extension Recent Developments
Table 115. Garden of Life Corporation Information
Table 116. Garden of Life Description and Major Businesses
Table 117. Garden of Life Product Models, Descriptions and Specifications
Table 118. Garden of Life Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 119. Garden of Life Recent Developments
Table 120. Suntory Holdings Corporation Information
Table 121. Suntory Holdings Description and Major Businesses
Table 122. Suntory Holdings Product Models, Descriptions and Specifications
Table 123. Suntory Holdings Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 124. Suntory Holdings Recent Developments
Table 125. Thorne Research Corporation Information
Table 126. Thorne Research Description and Major Businesses
Table 127. Thorne Research Product Models, Descriptions and Specifications
Table 128. Thorne Research Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 129. Thorne Research Recent Developments
Table 130. Meiji Holdings Co. Corporation Information
Table 131. Meiji Holdings Co. Description and Major Businesses
Table 132. Meiji Holdings Co. Product Models, Descriptions and Specifications
Table 133. Meiji Holdings Co. Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 134. Meiji Holdings Co. Recent Developments
Table 135. Swanson Health Products Corporation Information
Table 136. Swanson Health Products Description and Major Businesses
Table 137. Swanson Health Products Product Models, Descriptions and Specifications
Table 138. Swanson Health Products Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 139. Swanson Health Products Recent Developments
Table 140. Herbalife Nutrition Corporation Information
Table 141. Herbalife Nutrition Description and Major Businesses
Table 142. Herbalife Nutrition Product Models, Descriptions and Specifications
Table 143. Herbalife Nutrition Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 144. Herbalife Nutrition Recent Developments
Table 145. USANA Health Sciences Corporation Information
Table 146. USANA Health Sciences Description and Major Businesses
Table 147. USANA Health Sciences Product Models, Descriptions and Specifications
Table 148. USANA Health Sciences Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 149. USANA Health Sciences Recent Developments
Table 150. MegaFood Corporation Information
Table 151. MegaFood Description and Major Businesses
Table 152. MegaFood Product Models, Descriptions and Specifications
Table 153. MegaFood Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 154. MegaFood Recent Developments
Table 155. Nutrascriptives Corporation Information
Table 156. Nutrascriptives Description and Major Businesses
Table 157. Nutrascriptives Product Models, Descriptions and Specifications
Table 158. Nutrascriptives Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 159. Nutrascriptives Recent Developments
Table 160. Sisterly Corporation Information
Table 161. Sisterly Description and Major Businesses
Table 162. Sisterly Product Models, Descriptions and Specifications
Table 163. Sisterly Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 164. Sisterly Recent Developments
Table 165. Key Raw Materials Distribution
Table 166. Raw Materials Key Suppliers
Table 167. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 168. Milestones in Production Technology Evolution
Table 169. Distributors List
Table 170. Market Trends and Market Evolution
Table 171. Market Drivers and Opportunities
Table 172. Market Challenges, Risks, and Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources


List of Figures
Figure 1. Hormonal Supplements Product Picture
Figure 2. Global Hormonal Supplements Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Tablets Product Picture
Figure 4. Liquid Product Picture
Figure 5. Powders Product Picture
Figure 6. Chewables Product Picture
Figure 7. Capsules Product Picture
Figure 8. Global Hormonal Supplements Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Online Sales
Figure 10. Offline Sales
Figure 11. Hormonal Supplements Report Years Considered
Figure 12. Global Hormonal Supplements Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 14. Global Hormonal Supplements Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Hormonal Supplements Revenue Market Share by Region (2020-2031)
Figure 16. Global Hormonal Supplements Sales (2020-2031) & (Tons)
Figure 17. Global Hormonal Supplements Sales (CAGR) by Region (2020-2031) (Tons)
Figure 18. Global Hormonal Supplements Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Hormonal Supplements Sales Volume Market Share in 2024
Figure 20. Global Hormonal Supplements Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Tablets Revenue Market Share by Manufacturer in 2024
Figure 23. Liquid Revenue Market Share by Manufacturer in 2024
Figure 24. Powders Revenue Market Share by Manufacturer in 2024
Figure 25. Chewables Revenue Market Share by Manufacturer in 2024
Figure 26. Capsules Revenue Market Share by Manufacturer in 2024
Figure 27. Global Hormonal Supplements Sales Market Share by Type (2020-2031)
Figure 28. Global Hormonal Supplements Revenue Market Share by Type (2020-2031)
Figure 29. Global Hormonal Supplements Sales Market Share by Application (2020-2031)
Figure 30. Global Hormonal Supplements Revenue Market Share by Application (2020-2031)
Figure 31. North America Hormonal Supplements Sales YoY (2020-2031) & (Tons)
Figure 32. North America Hormonal Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 33. North America Top 5 Manufacturers Hormonal Supplements Sales Revenue (US$ Million) in 2024
Figure 34. North America Hormonal Supplements Sales Volume (Tons) by Type (2020- 2031)
Figure 35. North America Hormonal Supplements Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Hormonal Supplements Sales Volume (Tons) by Application (2020-2031)
Figure 37. North America Hormonal Supplements Sales Revenue (US$ Million) by Application (2020-2031)
Figure 38. US Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 39. Canada Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 40. Mexico Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 41. Europe Hormonal Supplements Sales YoY (2020-2031) & (Tons)
Figure 42. Europe Hormonal Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Manufacturers Hormonal Supplements Sales Revenue (US$ Million) in 2024
Figure 44. Europe Hormonal Supplements Sales Volume (Tons) by Type (2020-2031)
Figure 45. Europe Hormonal Supplements Sales Revenue (US$ Million) by Type (2020-2031)
Figure 46. Europe Hormonal Supplements Sales Volume (Tons) by Application (2020-2031)
Figure 47. Europe Hormonal Supplements Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. Germany Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 49. France Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 50. U.K. Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 51. Italy Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 52. Russia Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Hormonal Supplements Sales YoY (2020-2031) & (Tons)
Figure 54. Asia-Pacific Hormonal Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Top 8 Manufacturers Hormonal Supplements Sales Revenue (US$ Million) in 2024
Figure 56. Asia-Pacific Hormonal Supplements Sales Volume (Tons) by Type (2020- 2031)
Figure 57. Asia-Pacific Hormonal Supplements Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 58. Asia-Pacific Hormonal Supplements Sales Volume (Tons) by Application (2020-2031)
Figure 59. Asia-Pacific Hormonal Supplements Sales Revenue (US$ Million) by Application (2020-2031)
Figure 60. Indonesia Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 61. Japan Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 62. South Korea Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 63. China Taiwan Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 64. India Hormonal Supplements Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America Hormonal Supplements Sales YoY (2020-2031) & (Tons)
Figure 66. Central and South America Hormonal Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Central and South America Top 5 Manufacturers Hormonal Supplements Sales Revenue (US$ Million) in 2024
Figure 68. Central and South America Hormonal Supplements Sales Volume (Tons) by Type (2021-2031)
Figure 69. Central and South America Hormonal Supplements Sales Revenue (US$ Million) by Type (2020-2031)
Figure 70. Central and South America Hormonal Supplements Sales Volume (Tons) by Application (2020-2031)
Figure 71. Central and South America Hormonal Supplements Sales Revenue (US$ Million) by Application (2020-2031)
Figure 72. Brazil Hormonal Supplements Revenue (2020-2025) & (US$ Million)
Figure 73. Argentina Hormonal Supplements Revenue (2020-2025) & (US$ Million)
Figure 74. Middle East, and Africa Hormonal Supplements Sales YoY (2020-2031) & (Tons)
Figure 75. Middle East and Africa Hormonal Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Middle East and Africa Top 5 Manufacturers Hormonal Supplements Sales Revenue (US$ Million) in 2024
Figure 77. Middle East and Africa Hormonal Supplements Sales Volume (Tons) by Type (2021-2031)
Figure 78. South America Hormonal Supplements Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Middle East and Africa Hormonal Supplements Sales Volume (Tons) by Application (2020-2031)
Figure 80. Middle East and Africa Hormonal Supplements Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. GCC Countries Hormonal Supplements Revenue (2020-2025) & (US$ Million)
Figure 82. Turkey Hormonal Supplements Revenue (2020-2025) & (US$ Million)
Figure 83. Egypt Hormonal Supplements Revenue (2020-2025) & (US$ Million)
Figure 84. South Africa Hormonal Supplements Revenue (2020-2025) & (US$ Million)
Figure 85. Hormonal Supplements Industry Chain Mapping
Figure 86. Regional Hormonal Supplements Manufacturing Base Distribution (%)
Figure 87. Global Hormonal Supplements Production Market Share by Region (2020-2031)
Figure 88. Hormonal Supplements Production Process
Figure 89. Regional Hormonal Supplements Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit